Bill
National Health Amendment (Simplified Price Disclosure) Bill 2013
passed, as at 2014-03-13. Health portfolio.
- Sponsor
- Not recorded
- Portfolio
- Health
Recorded stages
- introduced — 2013-11-21
- second reading — 2013-11-21
- second reading — 2013-12-05
- second reading — 2013-12-05
- third reading — 2013-12-05
- introduced — 2013-12-05
- second reading — 2013-12-05
- second reading — 2014-03-05
- second reading — 2014-03-05
- committee — 2014-03-05
- third reading — 2014-03-05
- passed — 2014-03-05
- royal assent — 2014-03-13
Divisions
No divisions recorded. Most questions are decided on the voices; this does not establish that a bill was unopposed.
Plain-language summary
Written by a model from the explanatory memorandum; not the record, as at 2013-11-21.
This bill would simplify how the government adjusts drug prices under the Pharmaceutical Benefits Scheme.
It would merge all medicines into a single price disclosure cycle and shorten each cycle from 18 months to 12 months.
The first price reduction under the changes would occur on 1 October 2014, with a test requiring the market price to be at least 10% below the PBS price before a reduction applies.
- The bill merges all medicines into one ongoing price disclosure cycle.
- It shortens each price disclosure cycle from 18 months to 12 months.
- It applies a test requiring the market price to be at least 10% below the PBS price before a reduction takes effect.
The government, consumers, and drug companies supplying medicines under the PBS and RPBS.
Sources
em
billhome
frl act